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Summary: The effects of administration of ambilhar to guinea pigs intoxicated with lead for one and three weeks
were investigated. The results showed that administration of ambilhar to guinea pigs dosed with lead acetate resulted
in a significant decrease in the liver content of lead with a concomitant increase in urinary and faecal lead excretion.
The rate of lead elimination from the body was found to be dose depedent. The ultra violet studies of ambilhar and
its lead soluble complex in vitro supported the possibility that the stimulation of lead excretion results from the
formation of a lead-arnbilhar complex.
Untersuchungen über die Wirkung von Ambilhar auf die Mobilisierung und Ausscheidung von Blei
Zusammenfassung: Die Wirkungen der Verabreichung von Ambilhar an Meerschweinchen, die für eine Woche und
drei Wochen mit Bleiacetat vergiftet wurden, wurden untersucht. Ambilhar bewirkte bei den bleivergifteten Tieren
ein signifikante Minderung des Bleigehalts der Leber mit einem gleichzeitigen Anstieg der Bleiausscheidung in Faeces
und Urin.
Das Ausmaß der Bleielimination war dosisabhängig. Ultraviolett-spektroskopische Untersuchungen von Ambilhar und
seinem löslichen Bleikomplex in vitro unterstützen die Möglichkeit der Bindung von Blei an Ambilhar, wodurch die
Bleiausscheidung gefördert wird.
Introduction
Earlier studies on the antibilharzial drug ambilhar
revealed its metal ligating ability. Salah et al. (1) and
Abdel-Aziz et al. (2) demonstrated the excretion of iron
in the urine of man and animals after administration of
ambilhar.
In 1978 Al-Khayat et al. (3) reported similar effects on
body calcium and magnesium. The possibility that this
drug could form a similar complex with lead was there-
fore investigated.
The present work examines the possibility that ambilhar
forms a soluble lead complex in vivo as well as in vitro;




60 Male adult guinea pigs, average body weight 450-500 g, were
used in this study. They were fed with ordinary fresh vegetables
collected for animals in the college animal house. They were
divided into 6 equal groups.
The animals of groups 1, 2 and 3 were given lead acetate in a
daily dose level of 50 mg per animal intraperitoneally for 7 con-
secutive days. After this period the animals of groups 2 and 3
were treated with ambilhar at a daily dose level of 5 and 50 mg
per animal as an aqueous suspension administered by a stomach
tube for 7 consecutive days, while animals of group 1 were kept
as control. The urine and faeces of each animal were collected
daily in a metabolic cage. After the last day of ambilhar ad-
ministration, all animals of groups 1, 2 and 3 were sacrificed.
The animals of groups 4, 5 and 6 were given lead acetate intra-
peritoneally at the same dose level (50 mg per animal) daily for
21 consecutive days. Then animals of groups 5 and 6 were
treated with ambilhar for 7 consecutive days at a daily dose
level of 5 and 50 mg per animal, while animals of group 4 were
kept as control. The urine and faeces of each animal were col-
lected daily hi a metabolic cage. After the last day of ambilhar
administration, all animals of groups 4, 5 and 6 were sacrificed.
Estimation of lead content of liver, urine and faeces
One gram samples of fresh liver from each animal were exactly
weighed. One ml of urine and one gram of faeces from mixed
urine and mixed faecal matter of each group were used for
analysis. All samples were dried at 105 °C and then ashed in a
muffle furnace at 600 °C for 5 hours. The ash was used for the
determination of lead after dissolving in 2 ml of 20 g/1 acetic
acid. Estimation of the lead content of each sample was per-
formed using a Perkin-Elmer 503 atomic absorption spectro-
photometer (4).
A working stock standard solution of lead acetate was prepared
by dissolving one gram pure powdered lead acetate (BDH) in
one liter of 20 g/1 acetic acid. One ml of this stock solution was
diluted to one liter using 20 g acetic acid and used as a daily
working standard for a calibration curve.
0340-076X/81/0019-0021 $02.00
© by Walter de Gruy ter & Co. - Berlin · New York
Al-Khayat and Ab del Aziz: Effects of ambilhar on mobilisation and excretion of lead
In vitro investigations
To 500 mg pure lead acetate (BDH) one gram pure ambilhar
(Ciba-Geigy Labs) and two grams sodium metabisulphite (BDH)
were added. The whole mixture was pulverised in a mortar and
transferred to a 500 ml beaker. Distilled water (25 ml) was added
to the mixture with gentle warming on a waterbath at 70 °C for
10 minutes, where a clear colorless solution was obtained with
the remaining excess lead acetate on the bottom. It was filtered,
concentrated to about 5 ml under reduced pressure and left in
a refrigerator; crystalline white needles were obtained which by
ignition decomposed leaving a white residue of lead oxide.
A few crystals were dissolved in 5 ml distilled water and its
ultra violet spectrum was measured (fig. 1). The crystalline
needles were found to contain 69% lead. The soluble complex
formed runs as a single spot on ascending paper chromatography
using Whatman No. 1 filter paper with ;j-butanol, acetic acid and
water (volumes, 20 ml + 20 ml + 10 ml) as a solvent system.
0
Results
Table 1 shows the effect of ambilhar at two different
dose levels on liver lead content and on the urinary and
faecal lead excretion. A significant decrease of liver
lead content with concomitant increase in urinary and
faecal lead output was observed with the two dose levels
of ambilhar (5 and 50 mg per animal per day). With the
higher dose level the drug showed a more significant effect
on liver lead depletion, and on urinary and faecal lead
excretion. At a dose level of 5 mg of ambilhar, about
80% of liver lead was depleted, and at a dose level of
50 mg nearly all the metal was eliminated from the liver.
Table 2 shows the effect of ambilhar on the lead content
of the liver, urine and faeces after prolonged administra-
tion of lead acetate for three weeks. At a lower dose
level of ambilhar (5 mg per animal per day) for 7 con-
secutive days, about 50% of liver lead was removed,
while at the higher dose level (50 mg per animal per day)
about 84% of liver lead was eliminated. Also a significant
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Fig. 1. Spectral changes of ambilhar upon addition of sodium
metabisulphite and lead acetate.
It is clear that the peak at 370 nm in the drug ( — ) is
slightly reduced after the addition of sodium metabisul-
phite (reducing agent) (-. — ). However after the addition
of lead acetate to this mixture ( ) complete disappear-
ance of this peak was observed. This probably indicates
the formation of a soluble ambilhar lead complex.
Tab. 2. Effect of ambilhar administration on liver content of
lead after injection of lead acetate for three weeks
(50 mg per animal per day).
Group of animals Num- Liver Urinary Faecal
Group 4
ber lead lead lead
of
ani- mg/kg mg/1 mg/kg
mals fr. wt. fr. wt.
10 12.5 0.17 0.04
dosed with lead ± (2.5) ± (0.05) ± (0.065)
Tab. 1. Effect of ambilhar administration on the liver content of
lead after injection of lead acetate for one week
(50 mg per animal per day).
Group of animals Num- Liver Urinary Faecal
ber lead lead lead
of
ani- mg/kg mg/1 mg/kg
mals fr. wt. fr. wt.
Group 1 10 5.5 0.05 0.03
dosed with lead ± (0.25) ± (0.035) ± (0.02)
only (control)
Group 2 , 10 1.25** 0.35** 0.20**
dosed with ± (0.16) ± (0.1) ± (0.11)
5 mg ambilhar
after lead
Group 3 10 0.15** 0.96** 0.55**










10 6.4** 1.75** 1.55**
± (1.25) ± (0.35) ± (0.55)
10 2.2** 2.35** 1.95**




** significant at 1% level of probability
Figure 1 illustrates the ultra violet spectra of ambilhar
and its lead complex. It is clear that the peak at 370 nm
has disappeared upon the formation of the soluble
ambilhar lead complex. The effect of reducing agents
(sodium metabisulphite) on the complex formation was
± standard deviation
** significant at 1% level of probability
investigated by studying the absorption spectrum of the
drug in the absence of lead.
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It is clear from table 1 that administration of ambilhar
to guinea pigs intoxicated with lead for one week, results
in a significant urinary and faecal excretion of the metal
with a concomitant depletion of liver lead. At the lower
dose of the drug about 80% of liver lead was eliminated
and at the higher dose level about 97% of liver lead was
eliminated.
It is clear from table 2 that administration of ambilhar
to animals intoxicated with lead for three weeks, resulted
in a significant decrease in liver lead. On the other hand
a significant increase in urinary and faecal lead was ob-
served. At a lower dose level about 50% of liver lead was
eliminated and at the higher dose level of the drug about
84% of the metal in liver was eliminated.
Discussion
It is clear from table 1 that administration of ambilhar
resulted in a significant decrease in the lead content of
the liver. The degree of depletion of liver lead is dose-
dependent. At a dose level of 5 mg per animal for 7 con-
secutive days, about 80% of liver lead was eliminated,
while at a 50 mg dose level nearly complete depletion
of liver lead was observed.
The decrease of liver lead upon administration of the
drug was accompanied by a significant increase in urinary
and faecal lead excretion.
Table 2 shows the effect of ambilhar on liver lead after
intoxication of the liver with the metal for a longer
period (three weeks). At a dose level of 5 mg, the drug
caused a 50% decrease in the level of liver lead; at a
dose level of 50 mg, the decrease of liver lead was 84%.
A significant increase in urinary and faecal lead excre-
tion was also found.
These data show that ambilhar has the ability to form a
soluble complex with lead, which can be easily excreted.
This finding is also supported by the previous observa-
tions that ambilhar can easily form a complex with iron
(2) and with calcium and magnesium (3).
The ability of ambilhar to ligate and form a soluble com-
plex with lead is further supported by our in vitro
studies. The ultra violet spectrum of ambilhar was
found to be changed at 370 nm upon addition of lead
acetate in the presence of sodium metabisulphite,
presumably due to the formation of drug-lead complex
(fig. 1). Since the metal ligation ability of ambilhar
requires the presence of a reducing agent, it could be
inferred that the drug is reduced in vivo prior to its metal
ligation.
Compared to other lead antidotes ambilhar appears to
be less toxic, and therefore could be recommended for
treatment of lead intoxication.
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